Here's some of what is coming soon to NeurologyLive® this week.
News|Articles|September 14, 2026
This Week on NeurologyLive® — September 14, 2026
Author(s)Isabella Ciccone, MPH
Listen
0:00 / 0:00
Key Takeaways
- A weekly editorial preview frames upcoming NeurologyLive web coverage and signals priority neurology topics scheduled for publication.
- Slide-based navigation enables rapid scanning of featured items, with direct click-through access to each piece of content.
Here's some of what is coming soon to NeurologyLive® this week.
Advertisement
Every week, the NeurologyLive® staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting on the website. As always, our weekly coverage extends beyond just these topics, so make sure to check out the rest of the site!
Click through the slides below to see what you can expect from our team this week. Click any slide to check out the content.
—————————————————
Advertisement
Related to this article
Here's some of what is coming soon to NeurologyLive® this week.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 23, 2026.
Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with M. Scott Perry, MD. [LISTEN TIME: 15 minutes]
Kim Henriksen, PhD, discusses research evaluating blood-based biomarkers of blood-brain barrier remodeling and immune cell activity in multiple sclerosis, including their potential to track treatment responses and inform future biomarker development.
Paul Melmeyer, MPP, Executive Vice President of Public Policy and Advocacy at the Muscular Dystrophy Association, discusses the Neuromuscular Advocacy Collaborative, its growing year-round presence, and what the group hopes to accomplish heading into the 2027 MDA Clinical and Scientific Conference.
Joanna Wardlaw, MD, Professor of Applied Neuroimaging at the University of Edinburgh, discusses the evolving understanding of cerebral small vessel disease, emerging therapeutic approaches, and the makings behind a successful trial.
Terry Livingston, PharmD, vice president of medical affairs at Octave Bioscience, discussed the evolving role of blood-based biomarkers in multiple sclerosis care.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Incorporating the Updated AAN/AHS Migraine Prevention Guideline Into Practice
2
World Stroke Day 2026: Closing the Gap Between Stroke Onset and the Emergency Call Number
3
Blood-Based Biomarkers for Monitoring Treatment Response in Multiple Sclerosis
4
Machine Learning Spots Early Signs of MS and NMOSD Years in Advance
5